U.S. Physical Therapy (USPH): Citizens Sees Strong Growth Outlook, Reiterates at Outperform

Citizens analyst Constantine Davides reiterated a Market Outperform rating and $113.00 price target on U.S. Physical Therapy (NYSE: USPH).

The analyst commented, "We have increasing conviction in USPH's ability to extend its double-digit EBITDA growth rate into 2026. We continue to model 16% profit growth in 2025, resulting from payor re-contracting efforts, strong demand for physical therapy services, and the impact from accretive acquisitions. We are focused on efficiency initiatives, M&A opportunities, the growth of USPH's home-based services, and management's view of the Medicare rate backdrop beyond 2027."

For an analyst ratings summary and ratings history on U.S. Physical Therapy click here. For more ratings news on U.S. Physical Therapy click here.

Shares of U.S. Physical Therapy closed at $88.93 yesterday.

You May Also Be Interested In

• Tesla Nears Unveiling of Radical New ‘Flying’ Roadster - The Information
• Adeia (ADEA) PT Raised to $50 at BWS Financial
• Piper Sandler Reiterates Overweight Rating on Estee Lauder (EL), 'F4Q26 Preview'